Literature DB >> 10887905

Mathematical modelling of nitric oxide activity in wound healing can explain keloid and hypertrophic scarring.

C A Cobbold1, J A Sherratt.   

Abstract

Keloid and hypertrophic lesions are both types of scarring pathologies which arise as a consequence of excess collagen deposition during the wound healing process. The exact mechanism by which this occurs is not understood and currently no effective treatment exists. In this paper, we study the possible role of nitric oxide in excess scar formation. In recent years, the physiological role of this free radical in mammalian tissue has been extensively studied; in particular numerous groups have studied its role in wound healing. We describe a mathematical model which offers a possible explanation for keloid scarring in terms of the presence of higher than normal nitric oxide concentrations related to the fact that nitric oxide stimulates synthesis of collagen by fibroblasts. As a consequence of this, we put forward a suggestion for a treatment strategy involving the surgical excision of the keloid lesion combined with the application of a low-dose nitric oxide inhibitor. In addition, we show that a quasi-steady-state analysis of our model reveals a possible approach to distinguishing between hypertrophic and keloid lesions, a task which has to date proven to be clinically difficult. We also present an extended model which confirms these results in the context of a more complicated and biologically more realistic system. The fuller model demonstrates additional features of keloid and hypertrophic scarring which we were not able to consider in the basic model, and as a consequence further supports our hypothesis that nitric oxide activity could play a key role in keloid scarring.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10887905     DOI: 10.1006/jtbi.2000.2012

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  8 in total

1.  Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells.

Authors:  Ubaldo E Martinez-Outschoorn; Renee M Balliet; Dayana B Rivadeneira; Barbara Chiavarina; Stephanos Pavlides; Chenguang Wang; Diana Whitaker-Menezes; Kristin M Daumer; Zhao Lin; Agnieszka K Witkiewicz; Neal Flomenberg; Anthony Howell; Richard G Pestell; Erik S Knudsen; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2010-08-28       Impact factor: 4.534

2.  Kinetic modeling of nitric-oxide-associated reaction network.

Authors:  Teh-Min Hu; William L Hayton; Susan R Mallery
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

3.  Translational systems biology of inflammation and healing.

Authors:  Yoram Vodovotz
Journal:  Wound Repair Regen       Date:  2010 Jan-Feb       Impact factor: 3.617

Review 4.  Systems-based approaches toward wound healing.

Authors:  Adrian Buganza Tepole; Ellen Kuhl
Journal:  Pediatr Res       Date:  2013-01-11       Impact factor: 3.756

5.  Combining experimental and mathematical modeling to reveal mechanisms of macrophage-dependent left ventricular remodeling.

Authors:  Yu-Fang Jin; Hai-Chao Han; Jamie Berger; Qiuxia Dai; Merry L Lindsey
Journal:  BMC Syst Biol       Date:  2011-05-05

Review 6.  Hypertrophic scars and keloids: Overview of the evidence and practical guide for differentiating between these abnormal scars.

Authors:  Grace C Limandjaja; Frank B Niessen; Rik J Scheper; Susan Gibbs
Journal:  Exp Dermatol       Date:  2020-07-06       Impact factor: 3.960

7.  Coupled Immunological and Biomechanical Model of Emphysema Progression.

Authors:  Mario Ceresa; Andy L Olivares; Jérôme Noailly; Miguel A González Ballester
Journal:  Front Physiol       Date:  2018-04-19       Impact factor: 4.566

8.  In silico study of principal sex hormone effects on post-injury synovial inflammatory response.

Authors:  Bethany Powell; Igal Szleifer; Yasin Y Dhaher
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.